v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Beginning balance ( in shares) at Dec. 31, 2023 14,098,888        
Beginning balance at Dec. 31, 2023 $ 1 $ 780,044 $ 26 $ (691,336) $ 88,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss       (39,834) (39,834)
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee stock purchase plan (in shares) 91,302        
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee stock purchase plan   (112)     (112)
Stock-based compensation   3,303     3,303
Cashless exercise of pre-funded warrants ( in shares) 639,823        
Unrealized losses from marketable securities     (6)   $ (6)
Ending balance ( in shares) at Dec. 31, 2024 14,830,013       14,830,013
Ending balance at Dec. 31, 2024 $ 1 783,235 20 (731,170) $ 52,086
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss       (8,611) (8,611)
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee stock purchase plan (in shares) 81,184        
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee stock purchase plan   (87)     (87)
Stock-based compensation   763     763
Cashless exercise of pre-funded warrants ( in shares) 1,048,291        
Cashless exercise of pre-funded warrants $ 1       1
Unrealized losses from marketable securities     (20)   (20)
Ending balance ( in shares) at Mar. 31, 2025 15,959,488        
Ending balance at Mar. 31, 2025 $ 2 783,911 0 (739,781) $ 44,132
Beginning balance ( in shares) at Dec. 31, 2024 14,830,013       14,830,013
Beginning balance at Dec. 31, 2024 $ 1 783,235 20 (731,170) $ 52,086
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss       (26,483) (26,483)
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee stock purchase plan (in shares) 199,682        
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee stock purchase plan   (128)     (128)
Stock-based compensation   2,308     2,308
Cashless exercise of pre-funded warrants ( in shares) 18,293,476        
Cashless exercise of pre-funded warrants $ 2 (2)      
Unrealized losses from marketable securities     (18)   $ (18)
Ending balance ( in shares) at Dec. 31, 2025 33,323,171       33,323,171
Ending balance at Dec. 31, 2025 $ 3 785,413 2 (757,653) $ 27,765
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss       (3,585) (3,585)
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee stock purchase plan (in shares) 29,687        
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee stock purchase plan   (15)     (15)
Stock-based compensation   474     474
Unrealized losses from marketable securities     (2)   $ (2)
Ending balance ( in shares) at Mar. 31, 2026 33,352,858       33,352,858
Ending balance at Mar. 31, 2026 $ 3 $ 785,872 $ 0 $ (761,238) $ 24,637